EMCURE PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
EMCURE PHARMACEUTICALS Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|
Revenues | ₹1,963 Cr | ₹2,002 Cr | ₹1,815 Cr | ₹1,668 Cr | ₹1,663 Cr | ₹1,556 Cr |
Expenses | ₹1,608 Cr | ₹1,621 Cr | ₹1,479 Cr | ₹1,361 Cr | ₹1,334 Cr | ₹1,261 Cr |
Operating Income | ₹355 Cr | ₹381 Cr | ₹336 Cr | ₹307 Cr | ₹329 Cr | ₹296 Cr |
Other Income | ₹4 Cr | ₹36 Cr | ₹23 Cr | ₹16 Cr | ₹1 Cr | ₹15 Cr |
Interest | ₹32 Cr | ₹46 Cr | ₹59 Cr | ₹61 Cr | ₹59 Cr | ₹52 Cr |
Depreciation | ₹97 Cr | ₹97 Cr | ₹94 Cr | ₹84 Cr | ₹70 Cr | ₹67 Cr |
Profit Before Tax | ₹230 Cr | ₹273 Cr | ₹207 Cr | ₹171 Cr | ₹198 Cr | ₹191 Cr |
Profit After Tax | ₹156 Cr | ₹202 Cr | ₹153 Cr | ₹120 Cr | ₹146 Cr | ₹141 Cr |
EPS | ₹8.11 | ₹10.29 | ₹7.95 | ₹6.27 | ₹7.69 | ₹7.21 |
Industry Peers & Returns | 1W | 1M | 1Y |
EMCURE PHARMACEUTICALS | -6.9% | -2.3% | NA |
SUN PHARMACEUTICAL INDUSTRIES | -1.3% | 4.7% | 3.3% |
DIVIS LABORATORIES | 1.9% | 1.5% | 41.9% |
CIPLA | 3.4% | 0.1% | -3.1% |
TORRENT PHARMACEUTICALS | -4.8% | 1.9% | 20.3% |
DR REDDYS LABORATORIES | -0.1% | -1% | -11.3% |
MANKIND PHARMA | -4% | 4% | -1.9% |
ZYDUS LIFESCIENCES | 0.2% | -2.8% | -15.6% |
LUPIN | -0.1% | -2% | 19.1% |
EMCURE PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.97 % |
Y-o-Y | 18.01 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹1,963 Cr | -1.97 | |
Sep2024 | ₹2,002 Cr | 10.29 | |
Jun2024 | ₹1,815 Cr | 8.84 | |
Dec2023 | ₹1,668 Cr | 0.27 | |
Sep2023 | ₹1,663 Cr | 6.87 | |
Jun2023 | ₹1,556 Cr | - |
EMCURE PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -6.90 % |
Y-o-Y | 7.77 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹355 Cr | -6.90 | |
Sep2024 | ₹381 Cr | 13.25 | |
Jun2024 | ₹336 Cr | 9.57 | |
Dec2023 | ₹307 Cr | -6.72 | |
Sep2023 | ₹329 Cr | 11.31 | |
Jun2023 | ₹296 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -4.99 % |
Y-o-Y | -8.69 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 18.07% | -4.99 | |
Sep2024 | 19.02% | 2.64 | |
Jun2024 | 18.53% | 0.65 | |
Dec2023 | 18.41% | -6.97 | |
Sep2023 | 19.79% | 4.16 | |
Jun2023 | 19% | - |
EMCURE PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -22.55 % |
Y-o-Y | 7.03 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹156 Cr | -22.55 | |
Sep2024 | ₹202 Cr | 32.09 | |
Jun2024 | ₹153 Cr | 27.42 | |
Dec2023 | ₹120 Cr | -17.88 | |
Sep2023 | ₹146 Cr | 3.46 | |
Jun2023 | ₹141 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -21.05 % |
Y-o-Y | -9.35 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 7.95 % | -21.05 | |
Sep2024 | 10.07 % | 19.74 | |
Jun2024 | 8.41 % | 17.13 | |
Dec2023 | 7.18 % | -18.13 | |
Sep2023 | 8.77 % | -3.20 | |
Jun2023 | 9.06 % | - |
EMCURE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -21.19 % |
Y-o-Y | 5.46 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹8.11 | -21.19 | |
Sep2024 | ₹10.29 | 29.43 | |
Jun2024 | ₹7.95 | 26.79 | |
Dec2023 | ₹6.27 | -18.47 | |
Sep2023 | ₹7.69 | 6.66 | |
Jun2023 | ₹7.21 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD